 medac also produces therapeutics for fibrinolysis along with diagnostic agents for infection diagnostics and oncology diagnostics.The corporation owns 50% of two subsidiaries, Oncotec GmbH in Dessau Germany and oncomed manufacturing a.s. in the Czech Republic city of Brno, for the production of highly effective, sterile pharmaceuticals like cytostatics.In addition to generic products, medac has also developed its own products, which primarily covers therapeutic niches (e.g.